Global Thyroid Cancer Diagnostics Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029

“Global Thyroid Cancer Diagnostics Market” is the title of an upcoming report offered by MarketResearch.Biz. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global thyroid cancer diagnostics market has been segmented on the basis of type, technique, end-use, as well as regions and countries.

Request Covid - 19 Impact

Overview:

The actual diagnosis of thyroid cancer is carried out with a biopsy, in which cells are removed from a suspicious area and examined in a lab. The simplest to determine if a thyroid nodule or lump is cancerous is with a Fine Needle Aspiration (FNA) of the thyroid nodule.

Dynamics:

The rising prevalence of thyroid cancer and the growing emphasis on precursory diagnosis and treatment is a primary that is expected to fuel revenue growth of the global thyroid cancer diagnostics market in the years to come. Increasing R&D being undertaken by key industry players towards the development of precise diagnostic systems to improve diagnosis and patient outcomes are also expected to boost the revenue growth of this market in the near future.

The lack of knowledge concerning causative factors and the late diagnosis of this disease are some of the factors that may restrain the revenue growth of the global thyroid cancer diagnostics market.

However, the increasing number of initiatives being undertaken by governing bodies and favorable reimbursement policies are expected to boost the revenue growth of the global thyroid cancer diagnostics market in the coming years.

Segmentation of the global thyroid cancer diagnostics market is as follows:

In terms of type, the papillary carcinoma segment accounted for the majority revenue shares of the global thyroid cancer diagnostics market in 2019. The follicular carcinomas segment came in second with respect to revenue generated in 2019.

On the basis of technique, the imaging segment accounted for the highest number of revenue shares of the global thyroid cancer diagnostics market in 2019.

With respect to end-use, the hospitals segment accounted for the highest number of revenue shares of the global thyroid cancer diagnostics market in 2019, owing to the increasing patient inflow for thyroid cancer diagnosis, increasing R&D investments in both developed and emerging economies, as well as growing consumer awareness concerning thyroid cancer. The research institutes segment is slated to register the highest rate of revenue growth over the next 10 years owing to increasing global funding towards cancer research.

Regional Segmentation and Analysis:

North America accounted for the majority revenue share of the global thyroid cancer diagnostics market in 2019, owing to the increase in overall healthcare expenditures, favorable government initiatives, and the presence of key industry players in the region.

The markets in the APAC region are expected to register the highest rate of revenue growth in the coming years due to the increasing prevalence of thyroid cancer, higher disposable incomes, and improving healthcare infrastructure facilities.

Segmentation of the Global Thyroid Cancer Diagnostics Market:

Segmentation by Type:

• Papillary Carcinoma
• Follicular Carcinoma
• Others

Segmentation by Technique:

• Blood Tests
• Imaging
• Biopsy
• Others

Segmentation by End-Use:

• Hospital Laboratories
• Cancer Diagnostic Centers
• Research Institutes
• Others

Segmentation by Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Abbott
• F.Hoffmann-La Roche Ltd.
• Thermo-Fisher Scientific Inc.
• Siemens Healthcare GmbH
• Bio-Rad Laboratories Inc.
• General Electric
• Koninklijke Philips N.V.
• Toshiba Corporation
• Agilent Technologies Inc.
• Illumina Inc.